COLLINGWOOD HEALTH LTD

Company Registration Number:
07716666 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

COLLINGWOOD HEALTH LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

COLLINGWOOD HEALTH LTD

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 106,851 41,176
Total fixed assets: 106,851 41,176
Current assets
Stocks: 3,142 2,439
Debtors:   366,531 352,665
Cash at bank and in hand: 60,434 31,159
Total current assets: 430,107 386,263
Creditors: amounts falling due within one year: 4 (513,007) (430,812)
Net current assets (liabilities): (82,900) (44,549)
Total assets less current liabilities: 23,951 (3,373)
Creditors: amounts falling due after more than one year:     (5,000)
Total net assets (liabilities): 23,951 (8,373)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 23,851 (8,473)
Shareholders funds: 23,951 (8,373)

The notes form part of these financial statements

COLLINGWOOD HEALTH LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 14 September 2026
and signed on behalf of the board by:

Name: Mark Partridge
Status: Director

The notes form part of these financial statements

COLLINGWOOD HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

COLLINGWOOD HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 44 46

COLLINGWOOD HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 75,157
Additions 86,534
At 31 December 2025 161,691
Depreciation
At 01 January 2025 33,981
Charge for year 21,718
On disposals (859)
At 31 December 2025 54,840
Net book value
At 31 December 2025 106,851
At 31 December 2024 41,176

COLLINGWOOD HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

Bank Loan £95,110 Invoice Discounting Finance £311,699 Asset Financing £60,109 Trade Creditors £112,606 Other Creditors £19,028 Taxation £42,485

COLLINGWOOD HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Loans to directors

Name of director receiving advance or credit: Mark Partridge
Description of the loan: Amounts owing to M. Partridge at the year-end amounted to £90,110 (2024 £79,406).
£
Balance at 01 January 2025 79,406
Advances or credits made: 14,400
Advances or credits repaid: 3,696
Balance at 31 December 2025 90,110